The effect of covid-19 vaccines on pneumothorax in geriatric patients hospItalized in intensive care unit due to covid-19
Acta Clinica Croatica
; 61(4):655-660, 2022.
Artículo
en Inglés
| EMBASE | ID: covidwho-20236092
ABSTRACT
In our study, we examined the effect of COVID-19 vaccination on the incidence of pneumothorax in intensive care patients over age 65. COVID-19 intensive care patients that presented to our department between April 2020 and May 2021 during the COVID-19 pandemic were evaluated retrospectively. Patients were divided into two main groups, i.e., before and after the vaccination period. Patients were evaluated retrospectively for the following parameters Gender, age, side of pneumothorax, mortality, discharge, comorbidity, and additional pleural complications. The total number of patients was 87, i.e., 66 patients before vaccination and 21 patients after vaccination. When patients in the pre- and post-vaccination period were compared, there was a significant difference in the incidence of pneumothorax between the two groups (p<0.05). Pneumothorax was less common after vaccination. When patients with pneumothorax and tube thoracostomy were evaluated according to pre- and post-vaccination mortality, mortality was significantly higher (89%) in the pre-vaccination period (p<0.05). We consider that COVID-19 vaccines used in patients aged over 65 reduced the incidence of pleural complications, especially pneumothorax. We think that mortality due to pneumothorax in patients over 65 years of age was lower during the vaccination period. In addition, we think that bilateral pneumothorax was more common in the non-vaccinated period. As a result, we think that life-threatening pneumothorax and similar complications could be reduced by increasing the number of vaccines made in the COVID-19 pandemic and spreading it around the world.Copyright © 2022, Dr. Mladen Stojanovic University Hospital. All rights reserved.
covid-19; COVID-19 vaccination; Geriatrics; Intensive Care Unit; Mortality; Pneumothorax; adult; article; comorbidity; complication; controlled study; coronavirus disease 2019; drug therapy; female; gender; geriatric patient; human; incidence; intensive care; major clinical study; male; pandemic; retrospective study; surgery; thoracostomy; vaccination; SARS-CoV-2 vaccine
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
EMBASE
Tipo de estudio:
Estudio experimental
/
Estudio observacional
/
Ensayo controlado aleatorizado
Tópicos:
Vacunas
Idioma:
Inglés
Revista:
Acta Clinica Croatica
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS